Enveda Therapeutics
Latest round
- Series E
Last raised
- Sep 2026
Total raised
- $848M
Investors
- 35
About Enveda Therapeutics
Based in California, US, and founded in 2019 by CEO Viswa Colluru, Enveda Therapeutics, Inc. is a biotechnology company that uses a uses a drug platform to construct and decode integrated datasets of anthropological, biological, and chemical information from medicinal plants to inspire new medicines. In September 2026, Enveda Therapeutics, Inc. Enveda uses advanced technology to leverage natural products for drug discovery. The company’s platform identifies and harnesses the diverse chemical properties and biological activities found in nature, which traditional small molecule libraries cannot match. Enveda's approach includes discovering new medicines by exploring novel chemistries to manipulate disease-relevant proteins and uncovering new drug targets through the study of natural compounds. The firm’s pipeline focuses on therapies for inflammation, fibrosis, pain, and dermatological conditions, utilizing both oral and topical formulations. Enveda's technology platform overcomes challenges in bioactivity annotation and structure elucidation, providing a prolific source of next-generation compounds.
Who invested in Enveda Therapeutics
35 investors across 10 rounds
See all investors in Enveda Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Sep 23, 2026
Amount
$311M
Investors
Series D
Sep 4, 2025
Amount
$150M
Investors
Series C
Feb 26, 2025
Amount
$20M
Investors
Series C
Nov 21, 2024
Amount
$130M
Investors
Series B
Jun 14, 2024
Amount
$55M
Investors
Series B
Apr 20, 2023
Amount
$51M
Investors
Series B
Dec 21, 2022
Amount
$33M
Investors
Series B
Aug 25, 2022
Amount
$62M
Investors
Series A
Jun 22, 2021
Amount
$30M
Investors
Seed
Aug 11, 2020
Amount
$4.9M
Investors
Questions about Enveda Therapeutics
Who invested in Enveda Therapeutics?
Enveda Therapeutics has 35 investors on record across 10 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enveda Therapeutics raised?
Enveda Therapeutics has raised 10 venture rounds. Sign up free to see how much each round raised and the total.
When did Enveda Therapeutics last raise money?
Enveda Therapeutics's most recent round on record is a Series E, in Sep 2026.
What does Enveda Therapeutics do?
Based in California, US, and founded in 2019 by CEO Viswa Colluru, Enveda Therapeutics, Inc.
Where is Enveda Therapeutics headquartered?
Enveda Therapeutics is headquartered in Boulder, US.
Which VCs invest in companies like Enveda Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Enveda Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Enveda Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.